TITLE

Intraoperative anaphylaxis associated with bacitracin irrigation

AUTHOR(S)
Damm, Suzanne
PUB. DATE
February 2011
SOURCE
American Journal of Health-System Pharmacy;2/15/2011, Vol. 68 Issue 4, p323
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. Three cases of severe anaphylactic reactions associated with prophylactic bacitracin irrigation during cardiac procedures are describe. Summary. In all three cases, bacitracin irrigation was concentrated at 50,000 units per 10 mL and applied directly to the pacemaker pocket. The first case described involved an 88-year-old woman undergoing pacemaker insertion to correct bradycardia. Within 10 minutes of bacitracin irrigation, she lost consciousness and developed apnea, diffuse erythema, and hypotension. In the second case, a 69-year-old man receiving a cardiac resynchronization defibrillator implant developed apnea, hypotension, decreased pulse, erythema of the extremities, and a maculopapular rash within 15 minutes of bacitracin administration. The third case involved an 83-year-old woman undergoing a dual pacemaker battery change; she became agitated and was noted to have hypotension, anxiety, and other symptoms 8 minutes after bacitracin irrigation. Two of the three cases involved apnea and loss of consciousness, and all three patients developed erythema or rash. Application of the adverse drug reaction probability scale developed by Naranjo et al. yielded a score of 3 (indicating a possible adverse reaction to bacitracin) in all three cases. As in other published reports of anaphylactic reactions associated with bacitracin irrigation, development of hypotension within 15 minutes of bacitracin administration was the first sign of an adverse reaction in these cases. Conclusion. Three patients developed severe adverse reactions after prophylactic bacitracin irrigation, two during pacemaker insertions and one during a cardiac resynchronization defibrillator implantation.
ACCESSION #
58046067

 

Related Articles

  • Capsule Endoscopy in Patients with Cardiac Pacemakers and Implantable Cardioverter Defibrillators: (Re)evaluation of the Current State in Germany, Austria, and Switzerland 2010. Bandorski, Dirk; Jakobs, Ralf; Brück, Martin; Hoeltgen, Reinhard; Wieczorek, Marcus; Keuchel, Martin // Gastroenterology Research & Practice;2012, p1 

    Background and Aims. The study was a repeated evaluation of the experience of capsule endoscopy (CE) in patients with cardiac pacemaker or implantable cardioverter defibrillator (ICD). Patients and Methods. A standardized questionnaire was sent by the manufactors Given Imaging and Olympus to all...

  • Endoscopic electrosurgery--an overview. King, Charlotte // Gastrointestinal Nursing;May2011, Vol. 9 Issue 4, p28 

    Electrosurgery is an invaluable tool for even the most basic therapeutic endoscopic procedures including polypectomy, sphincterotomy, tissue ablation and the maintenance of haemostasis. It uses the production of heat by the flow of high frequency alternating electrical current through living...

  • Unusual cause of hypoxemia after automatic implantable cardioverter-defibrillatorleads extraction. Dinesh Raju; Roysam, Chandrika; Singh, Rajendra; Clark, Stephen C.; Plummer, Christopher; Raju, Dinesh // Annals of Cardiac Anaesthesia;Oct-Dec2015, Vol. 18 Issue 4, p599 

    The indication of pacemaker/AICD removal are numerous. Serious complication can occur during their removal, severe tricuspid regurgitation is one of the complication. The occurrence of PFO is not uncommon among adult population. Shunting across PFO in most circumstance is negligible, but in some...

  • ALTITUDE: highest survival rates ever reported in patients with ICDs or CRT-Ds. Rusk, Judith // Cardiology Today;Jul2009, Vol. 12 Issue 7, p13 

    The article discusses a study on the survival rates of patients with an implantable cardioverter defibrillator or a cardiac resynchronization therapy device.

  • Current Pacemaker and Defibrillator Therapy. Trappe, Hans-Joachim; Gummert, Jan // Deutsches Aerzteblatt International;5/27/2011, Vol. 108 Issue 21, p372 

    Background: Pacemakers have been available for 50 years, and implantable cardiac defibrillators for 25. Clear indications for each have been established on the basis of data from randomized clinical trials (RCTs). Methods: This review article is the product of a collaborative effort by a...

  • A postcode lottery for cardiac rhythm management? Turley, Andrew J.; Linker, Nicholas J. // British Journal of Cardiac Nursing;Mar2012, Vol. 7 Issue 3, p132 

    The author discusses the 2010 audit of the equity and level of provision of cardiac pacemakers (PPM), implantable defribrillators (ICD), and cardiac resynchronization therapy (CRT) of Heart Rhythm UK Audit Group (HRUK) for treatment of cardiac-related diseases. He states the potential of cardiac...

  • Gespeicherte Elektrogramme in Schrittmachern und ICDs der Firma St.�Jude Medical.  // Herzschrittmachertherapie und Elektrophysiologie;Mar2010, Vol. 21 Issue 1, p53 

    Stored electrograms (EGMs) significantly improve pacemaker and ICD therapy. In pacemaker systems, the main focus of stored EGMs concerns the manual control of device detection of atrial tachyarrhythmias, especially atrial fibrillation. In ICD therapy, stored EGMs allow the discrimination of...

  • Pacemaker & ICD Safety Issue Debated; Does More Advances Mean More Problems? Anast, David G. // Medical Design Technology;Sep2001, Vol. 5 Issue 9, p12 

    Focuses on the debated safety issue of pacemakers and implantable cardioverter defibrillators (ICD) in the United States. Subjection to manufacturer safety alerts and recalls for pacemakers and ICD; Identification of advisories involving pacemakers and ICD; Method to resolve safety issues of...

  • Continuing Warfarin for Pacemaker/ICD Implantation is Safer Than Bridging. Kuritzky, Louis // Internal Medicine Alert;7/15/2013 Clinical Briefs, p103 

    The article suggests that continuation of an anticoagulant warfarin for pacemaker implantation is safer than an injectable anticoagulant Heparin Bridging, and informs about the risk associated during transition from warfarin to heparin.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics